APC Resistance | Activated Protein C Resistance | Factor V Leiden

 

 

 ORDER: 1-800-526-5224 | SUPPORT: 1-800-447-3846 | ABOUT US | CONTACT US | HOME

ACTIVATED PROTEIN C RESISTANCE UNIVERSITY


Introduction | Biochemistry | Clinical Aspects | Key Reports | PubMed Abstracts | References

Assay Methods | APC Resistance Phenotyping | Factor V Mutation Screening | Products | FAQ


APC RESISTANCE PHENOTYPING

Coatest® APC™ Resistance is the classic APTT-based assay for the detection of the APC resistance phenotype, i.e. the poor anticoagulant response to activated protein C (APC). The test result (APC ratio) gives an estimation of the anticoagulant function in vivo and provides information on the thrombotic risk associated with inherited and possibly acquired APC resistance.

Assay procedure

Citrated and centrifuged plasma is incubated with the APTT reagent for a standard period of time. Coagulation is triggered by the addition of CaCl2 in the absence and presence of exogenous APC and the time for clot formation is recorded. The relationship between the two clotting times is expressed as an APC ratio.

Calibration

The actual APC ratio corresponding to a borderline response to APC may vary slightly depending on the type of instrumentation used as well as on the instrument condition. It is recommended that users establish their own cutoff value for their instrument as described in the kit insert.

Results

APC resistance is indicated when the APC ratio is below the cut-off value.

Kit Contents

1. CaCl2, 1 x 8 mL

0.025 mol/L in Tris buffer containing

0.5% bovine serum albumin.

2. APTT reagent, 1 x 16 mL

Purified phospholipid with colloidal silica as contact activator.

3. APC/CaCl2, 4 x 2 mL

Human APC colyophilized with CaCl2

Stability in solution (2–8 °C)

1. CaCl2, 1 month

2. APTT reagent, 1 month

3. APC/CaCl2, 5 days

Repeatability and precision

The reproducibility of the clotting times was determined in the presence and absence of APC by analysis of three plasma samples with varying responses to APC. The analyses were performed on 7 different occasions, including 5 replicates of each plasma. Instrument: ACL.

HRP = High response plasma

CPL1 = Control Plasma Level 1 (normal response)

CPL2 = Control Plasma Level 2 (low response)

 

CaCl2

Within series

Between series

HRP

29.9 s

CV=1.8%

CV=4.2%

CPL1

32.0 s

CV=2.0%

CV=3.9%

CPL2

32.2 s

CV=1.1%

CV=0.8%

 

 

APC/CaCl2

Within series

Between series

HRP

122 s

CV=2.4%

CV=2.0%

CPL1

116 s

CV=4.3%

CV=5.0%

CPL2

64.5 s

CV=1.4%

CV=1.6%

 

 

APC ratio

Between series

 

HRP

4.1

CV=5.0%

 

CPL1

3.6

CV=3.3%

 

CPL2

2.0

 CV=1.4%

 

Test limitations

Abnormal APTT, vitamin K antagonist therapy, heparin therapy.

Number of determinations per kit

80–160

Catalog #

K822643


Download this page as a .pdf (.zip)

 

ORDER LINE: 1-800-526-5224     TECH SUPPORT: 1-800-447-3846

ORDER

TOP